insights_auto
Why is TAK up ၂.၃၁%?
Dive Deeperchevron_right
TAK:NYSE
Takeda Pharmaceutical Co Ltd
၁၉.၄၅ US$
arrow_upward
+၂.၃၁%(+၀.၄၄) 1D
၁၉.၄၇ US$
arrow_upward
+၀.၁၀% (+၀.၀၂၀)bedtimeAfter hours
Closed: အောက် ၁၅, GMT-၄ ၁၆:၀၀:၀၆ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TAK...
Open
၁၉.၅၈ US$
High
၁၉.၈၉ US$
Low
၁၉.၄၅ US$
Mkt. cap
ဋေ ၆.၃၃ ထ
Avg. vol.
၂.၅၁ သန်း
Volume
၄.၃၉ သန်း
Dividend
၃.၂၄%
Quarterly dividend
၀.၁၆ US$
Ex-dividend date
၂၀၂၆ စက် ၂၉
52-wk high
၁၉.၈၉ US$
52-wk low
၁၂.၉၉ US$
EPS
-၀.၃၃ US$
Beta
-၀.၀၆
Shares outstanding
၃၂၀.၄၃ ဋေ
No. of employees
၅ သောင်း
Open
၁၉.၅၈ US$
High
၁၉.၈၉ US$
Low
၁၉.၄၅ US$
Mkt. cap
ဋေ ၆.၃၃ ထ
Avg. vol.
၂.၅၁ သန်း
Volume
၄.၃၉ သန်း
Dividend
၃.၂၄%
Quarterly dividend
၀.၁၆ US$
Ex-dividend date
၂၀၂၆ စက် ၂၉
52-wk high
၁၉.၈၉ US$
52-wk low
၁၂.၉၉ US$
EPS
-၀.၃၃ US$
Beta
-၀.၀၆
Shares outstanding
၃၂၀.၄၃ ဋေ
No. of employees
၅ သောင်း
News stories
From web sources and news partners
ad-hoc-news.de
·
ပြီးခဲ့သည့် ၁၆ နာရီ
Takeda schedules October 29 results call for Takeda stock
TradingView
·
ပြီးခဲ့သည့် ၂၀ နာရီ
Takeda Pharmaceutical Company Limited Stock 12‑Month Price Target Raised to $20.74, Implies 9% Upside
Yahoo Finance
·
ပြီးခဲ့သည့် ၁ ရက်
Takeda’s ORZEYFUL (oveporexton) Launches Simultaneously in Japan and China Giving Physicians First Access to Prescribe Novel Orexin Agonist to Patients with Narcolepsy Type 1
Stock Traders Daily
·
ပြီးခဲ့သည့် ၁ ရက်
Trading the Move, Not the Narrative: (TAK) Edition
Profile
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
About Takeda Pharmaceutical Co Ltd
CEOChristophe Weber | Christophe Weber
Employees၄.၇ သောင်း
Founded၁၇၈၁ ဇွန် ၁၂
Headquarters-
Sector-
Websitetakeda.com